Circulating Protein Signatures and Causal Candidates for Type 2 Diabetes

The increasing prevalence of type 2 diabetes poses a major challenge to societies worldwide. Blood-based factors like serum proteins are in contact with every organ in the body to mediate global homeostasis and may thus directly regulate complex processes such as aging and the development of common chronic diseases. We applied a data-driven proteomics approach, measuring serum levels of 4,137 proteins in 5,438 elderly Icelanders, and identified 536 proteins associated with prevalent and/or incident type 2 diabetes. We validated a subset of the observed associations in an independent case-control study of type 2 diabetes. These protein associations provide novel biological insights into the molecular mechanisms that are dysregulated prior to and following the onset of type 2 diabetes and can be detected in serum. A bidirectional two-sample Mendelian randomization analysis indicated that serum changes of at least 23 proteins are downstream of the disease or its genetic liability, while 15 proteins were supported as having a causal role in type 2 diabetes.

[1]  J. Danesh,et al.  Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic diseases , 2019, Nature Metabolism.

[2]  V. Regitz-Zagrosek,et al.  Sex differences in cardiometabolic disorders , 2019, Nature Medicine.

[3]  Stephen Burgess,et al.  Robust methods in Mendelian randomization via penalization of heterogeneous causal estimates , 2019, PloS one.

[4]  Zhaoping Li,et al.  Targeting BCAA Catabolism to Treat Obesity-Associated Insulin Resistance , 2019, Diabetes.

[5]  C. Schooling,et al.  The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study , 2019, Diabetologia.

[6]  B. Cheung,et al.  Evaluation of GDF15 as a therapeutic target of cardiometabolic diseases in human: A Mendelian randomization study , 2019, EBioMedicine.

[7]  C. Newgard,et al.  Branched-chain amino acids in disease , 2019, Science.

[8]  Ashish Jain,et al.  TissueEnrich: Tissue-specific gene enrichment analysis , 2018, Bioinform..

[9]  Sina A. Gharib,et al.  Unraveling the polygenic architecture of complex traits using blood eQTL metaanalysis , 2018, bioRxiv.

[10]  Anthony J. Payne,et al.  Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps , 2018, Nature Genetics.

[11]  Xia Yang,et al.  Co-regulatory networks of human serum proteins link genetics to disease , 2018, Science.

[12]  Jonathan D. G. Jones,et al.  Shifting the limits in wheat research and breeding using a fully annotated reference genome , 2018, Science.

[13]  C. Evans,et al.  Response to Comment on “An excess of massive stars in the local 30 Doradus starburst” , 2018, Science.

[14]  Stephen Burgess,et al.  Genomic atlas of the human plasma proteome , 2018, Nature.

[15]  Valeriia Haberland,et al.  The MR-Base platform supports systematic causal inference across the human phenome , 2018, eLife.

[16]  L. Groop,et al.  Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. , 2018, The lancet. Diabetes & endocrinology.

[17]  Thomas J. Wang,et al.  Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose , 2018, Diabetologia.

[18]  S. Humphries,et al.  Integrative studies implicate matrix metalloproteinase‐12 as a culprit gene for large‐artery atherosclerotic stroke , 2017, Journal of internal medicine.

[19]  Yuri Kotliarov,et al.  Assessment of Variability in the SOMAscan Assay , 2017, Scientific Reports.

[20]  Tanya M. Teslovich,et al.  An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans , 2017, Diabetes.

[21]  S. Thompson,et al.  Interpreting findings from Mendelian randomization using the MR-Egger method , 2017, European Journal of Epidemiology.

[22]  Huan Li,et al.  GDF11 Attenuates Development of Type 2 Diabetes via Improvement of Islet β-Cell Function and Survival , 2017, Diabetes.

[23]  Christian Gieger,et al.  Connecting genetic risk to disease end points through the human blood plasma proteome , 2016, Nature Communications.

[24]  Nicholas J Wareham,et al.  A Systematic Review of Biomarkers and Risk of Incident Type 2 Diabetes: An Overview of Epidemiological, Prediction and Aetiological Research Literature , 2016, PloS one.

[25]  Stephen C. J. Parker,et al.  The genetic architecture of type 2 diabetes , 2016, Nature.

[26]  Hedi Peterson,et al.  g:Profiler—a web server for functional interpretation of gene lists (2016 update) , 2016, Nucleic Acids Res..

[27]  Frank B Hu,et al.  Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis , 2016, Diabetes Care.

[28]  Manolis Kellis,et al.  HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease , 2015, Nucleic Acids Res..

[29]  Johan Sundström,et al.  Protein Biomarkers for Insulin Resistance and Type 2 Diabetes Risk in Two Large Community Cohorts , 2015, Diabetes.

[30]  S. Banerjee,et al.  GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective , 2015, Journal of diabetes research.

[31]  M. Persson,et al.  Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[32]  Eric P. Hoffman,et al.  Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy , 2015, Proceedings of the National Academy of Sciences.

[33]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[34]  G. Davey Smith,et al.  Mendelian randomization: genetic anchors for causal inference in epidemiological studies , 2014, Human molecular genetics.

[35]  Tanya M. Teslovich,et al.  Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility , 2014, Nature Genetics.

[36]  Thomas Kocher,et al.  1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control. , 2014, The Journal of clinical endocrinology and metabolism.

[37]  Max Kuhn,et al.  Applied Predictive Modeling , 2013 .

[38]  J. Pankow,et al.  Novel Risk Factors and the Prediction of Type 2 Diabetes in the Atherosclerosis Risk in Communities (ARIC) Study , 2012, Diabetes Care.

[39]  Daniel O'Connell,et al.  Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets , 2012, Proceedings of the National Academy of Sciences.

[40]  Tanya M. Teslovich,et al.  Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.

[41]  O. Gavrilova,et al.  Myostatin Inhibition Prevents Diabetes and Hyperphagia in a Mouse Model of Lipodystrophy , 2012, Diabetes.

[42]  E. Goldsmith,et al.  Diabetes-Induced Alterations in the Extracellular Matrix and Their Impact on Myocardial Function , 2012, Microscopy and Microanalysis.

[43]  W. Rathmann,et al.  Immunological and Cardiometabolic Risk Factors in the Prediction of Type 2 Diabetes and Coronary Events: MONICA/KORA Augsburg Case-Cohort Study , 2011, PloS one.

[44]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[45]  Chi-Hong Tseng,et al.  The lack of utility of circulating biomarkers of inflammation and endothelial dysfunction for type 2 diabetes risk prediction among postmenopausal women: the Women's Health Initiative Observational Study. , 2010, Archives of internal medicine.

[46]  Tracy R. Keeney,et al.  Aptamer-based multiplexed proteomic technology for biomarker discovery , 2010, PloS one.

[47]  V. Salomaa,et al.  Thirty-One Novel Biomarkers as Predictors for Clinically Incident Diabetes , 2010, PloS one.

[48]  L. Patthy,et al.  Both WFIKKN1 and WFIKKN2 Have High Affinity for Growth and Differentiation Factors 8 and 11* , 2008, Journal of Biological Chemistry.

[49]  M. Furuhashi,et al.  Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets , 2008, Nature Reviews Drug Discovery.

[50]  Ralph B D'Agostino,et al.  Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. , 2007, Archives of internal medicine.

[51]  V. Gudnason,et al.  Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. , 2007, American journal of epidemiology.

[52]  David Roth,et al.  A simplified equation to predict glomerular filtration rate from serum creatinine , 2000 .

[53]  J. Griffin,et al.  Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome. , 2014, The lancet. Diabetes & endocrinology.

[54]  K. Lunetta,et al.  Methods in Genetics and Clinical Interpretation Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Design of Prospective Meta-Analyses of Genome-Wide Association Studies From 5 Cohorts , 2010 .